Evidence map›Paper›PMID 16556301›Full record

ArticleJournal of negative results in biomedicine2006

Role of HOXA7 to HOXA13 and PBX1 genes in various forms of MRKH syndrome (congenital absence of uterus and vagina).

Agnès Burel, Thomas Mouchel, Sylvie Odent, Filiz Tiker, Bertrand Knebelmann, Isabelle Pellerin, Daniel Guerrier

Open access · hybridAbstract readCase Reports
In one paragraph

Article in Journal of negative results in biomedicine, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
5.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 81 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Detection ofEuropean journal of obstetrics & gynecology and reproductive biology: X · 2019
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Mayer-rokitansky-kuster-hauser syndrome: surgical management of two cases.Journal of surgical technique and case report · 2010
    Article
  14. Article
  15. Müllerian duct anomalies: review of current management.Sao Paulo medical journal = Revista paulista de medicina · 2009
    Review
  16. Article
  17. Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome.Orphanet journal of rare diseases · 2007
    Review
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 2 countries.

Agnès BurelCNRS UMR 6061, Génétique et Développement, Université de Rennes 1, Groupe IPD, IFR140 GFAS, Faculté de Médecine, Rennes, France. agnes.burel@univ-rennes1.fr
Thomas Mouchel
Sylvie Odent
Filiz Tiker
Bertrand Knebelmann
Isabelle Pellerin
Daniel Guerrier
Adana Hospital · TRCentre Hospitalier Universitaire de Rennes · FRCentre National de la Recherche Scientifique · FRHôpital Necker-Enfants Malades · FRInstitut de génétique et de développement de Rennes · FRUniversité de Rennes · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome refers to the congenital absence or severe hypoplasia of the female genital tract, often described as uterovaginal aplasia which is the prime feature of the syndrome. It is the second cause of primary amenorrhea after gonadal dysgenesis and occurs in approximately 1 in 4500 women. Aetiology of this syndrome remains poorly understood. Frequent association of other malformations with the MRKH syndrome, involving kidneys, skeleton and ears, suggests the involvement of major developmental genes such as those of the HOX family. Indeed mammalian HOX genes are well known for their crucial role during embryogenesis, particularly in axial skeleton, hindbrain and limb development. More recently, their involvement in organogenesis has been demonstrated notably during urogenital differentiation. Although null mutations of HOX genes in animal models do not lead to MRKH-like phenotypes, dominant mutations in their coding sequences or aberrant expression due to mutated regulatory regions could well account for it. Sequence analysis of coding regions of HOX candidate genes and of PBX1, a likely HOX cofactor during Müllerian duct differentiation and kidney morphogenesis, did not reveal any mutation in patients showing various forms of MRKH syndrome. This tends to show that HOX genes are not involved in MRKH syndrome. However it does not exclude that other mechanisms leading to HOX dysfunction may account for the syndrome.

Indexed as

Abnormalities, MultipleAdolescentAdultDNA-Binding ProteinsFemaleHomeodomain ProteinsHumansPre-B-Cell Leukemia Transcription Factor 1Proto-Oncogene ProteinsSequence Analysis, DNASyndromeUterusVaginaDNA-Binding Proteinshomeobox protein HOXA13Homeodomain ProteinsHOXA7 protein, humanPBX1 protein, humanPre-B-Cell Leukemia Transcription Factor 1Proto-Oncogene Proteins

Identifiers

PMID16556301
PMCPMC1444933
OpenAlexW1598952385

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.